Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 65   

Articles published

PFE 32.18 -0.36 (-1.11%)
price chart
Goodbye, Lipitor. Pfizer Bids a Farewell
Pfizer officials told The Wall Street Journal that the company is no longer negotiating new contracts to sell Lipitor to health plans, which are signing up to sell generic versions at far lower prices.
Pfizer announces results from Lyrica clinical studies on fibromyalgia
Pfizer Inc. (NYSE: PFE) announced the results of studies on Lyrica� (pregabalin) capsules CV presented at the American Pain Society Annual Meeting in Honolulu.
Pfizer Gets Support For Arthritis Drug Approval
Pfizer Inc. (NYSE:PFE) has moved one step closer to approval of a drug that will improve options in the treatment of Rheumatoid Arthritis.
Report: Pfizer voluntarily recalled 650000 bottles of Advil Liqui-Gels
Advil.jpg AP/FILEPfizer Inc. voluntarily recalled more than 650,000 bottles of Advil Liqui-Gels, due to an unusually strong odor.
Mylan Denied Invalidity In Cancer Drug IP Battle
Law360, New York (May 2, 2012, 5:42 PM EDT) -- A Delaware federal judge Tuesday found in favor of Genentech Inc., Pfizer Inc. and Astellas Pharma Inc. unit OSI Pharmaceuticals Inc. in their patent infringement suit against Mylan Pharmaceuticals Inc ...
Google's Brin Makes Strides in Hunt for Parkinson's Cure
Sergey Brin, the 38-year-old co-founder of Google Inc., is making strides in his quest to find a cure for Parkinson's, a progressive disease his DNA and family history suggest may afflict him as early as 10 years from now.
Pfizer recalls 650000 bottles of Advil Liqui-Gels
Pfizer Inc. has recalled more than 650,000 bottles of Advil pain-relief medicine due to the potential for a strong odor in the product.
Personalized Rx for Children
In 2010 a Pfizer-sponsored study showed it shrank or stabilized tumors in 90% of 82 patients whose tumors had an aberration in the ALK gene.
Dow Chemical taking Pfizer space
COLLEGEVILLE —Dow Chemical Co. has finalized a long-term lease on 800,000 square feet of space at Pfizer Inc.'s campus here in what is one of the largest lease deals to be struck in the suburban office market.
Teva Pharmaceuticals not to launch Atorvastatin, generic version of Lipitor
NEW DELHI: Israel's Teva Pharmaceuticals will not launch atorvastatin, the generic version of the world's best-selling drug, Lipitor, that will help Indian companies Ranbaxy Laboratories and Dr Reddy's Laboratories garner larger sales of the medicine ...